Halia News & Updates
Zurück zum ProfilHol dir die neuesten Nachrichten, Updates und Inhalte über Halia. Verpasse keinen Klatsch oder neuen Content deines Lieblingsstars.
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025
LEHI, Utah, Dec. 8, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical comp...
Halia Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference
LEHI, Utah, May 28, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., The Genetic Resilience Company™...
How LeVanta Tech's HALIA gets off the water
LeVanta Tech, a defence startup based in Diamondhead, Mississippi, is building HALIA, an uncrewed ai...
Halia Therapeutics Announces Positive Topline Data and Advances to Second Stage of Phase 2 Clinical Trial for HT-6184 in Patients with Low-Risk Myelodysplastic Syndromes (LR-MDS)
LEHI, Utah, Dec. 10, 2024 /PRNewswire/ -- Halia Therapeutics, a biopharmaceutical company at the for...
Halia Therapeutics Presents Two AAIC 2026 Posters on HT-4253 for Alzheimer's Prevention in APOE4 Carriers
Preclinical data show HT-4253 reduces neuroinflammation and tau pathology; a second details a Phase ...
Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets
New CSO & GM role underscores Halia's commitment to resilience-based therapeutic development and adv...
Halia Therapeutics to Present an Update on Phase II Clinical Trial Data of HT-6184 at the 6th Inflammasome Therapeutics Summit
LEHI, Utah, Sept. 10, 2024 /PRNewswire/ -- Halia Therapeutics, Inc. (Halia), a clinical-stage biopha...
Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting
The MarketWatch News Department was not involved in the creation of this content. - Data demonstrate...
Halia Therapeutics Appoints Gary Sabin as Executive Chairman and Adds Three Independent Directors to Board
Industry leaders join at a pivotal moment as company advances HT-6184 toward a pivotal trial in MDS ...
Halia Therapeutics CEO Dr. David Bearss to Deliver Keynote Address at Med Investment Forum 2025 in Abu Dhabi
ABU DHABI, UAE, May 29, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical ...
(CNW) Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting
The MarketWatch News Department was not involved in the creation of this content. - Data demonstrate...
Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer
European Hematology Association (EHA) oral presentation to report 67% hematological improvement, dur...
Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
LEHI, Utah, Sept. 9, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutic...
Singapore restaurant Halia to shut down after 25 years
The Halia Restaurant at the Singapore Botanic Gardens will close in mid-March after 25 years of oper...
Enrolment concludes in Halia’s Phase IIa trial of HT-6184 for MDS
Halia Therapeutics has completed the enrolment in its Phase IIa trial of HT-6184 (Ofirnoflast) in th...
Halia Therapeutics Wins Novo Nordisk Golden Ticket
The biotech won the award for its work in obesity and inflammation treatment. The Novo Nordisk Golde...
Halia Therapeutics Receives FDA Fast Track Designation for Ofirnoflast (HT-6184) in Lower-Risk Myelodysplastic Syndromes
LEHI, Utah, June 15, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutic...
Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit
LEHI, Utah, March 2, 2026 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical com...
Halia Therapeutics Dosed Its First Patient In Phase 2A Clinical Trial Of HT-6184, A First-In-Class NLRP3-Inhibitor, For The Treatment Of Lower-Risk Myelodysplastic Syndromes
(MENAFN- PR Newswire) LEHI, Utah, Dec. 13, 2023 /PRNewswire/ -- Halia Therapeutics, a clinical-stage...
Halia Therapeutics to Present at the 17th Annual Pain Therapeutics Summit
LEHI, Utah, Oct. 18, 2023 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical com...
The Halia
Nestled in the lush greenery of the Botanic Gardens lies a long-established restaurant called The Ha...
M42’s IROS launches UAE’s first genomics-driven clinical trial to prevent Alzheimer’s disease
ABU DHABI, 29th June, 2026 (WAM) -- M42’s Insights Research Organisation and Solutions (IROS), in ...
Halia Therapeutics receives FDA Fast Track designation for ofirnoflast in myelodysplastic syndromes
LEHI, Utah, June 15, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutic...
Halia at Botanic Gardens gets Halal certification
Fusion restaurant Halia at the Singapore Botanic Gardens is now officially Halal-certified. The icon...
Halia Therapeutics Awarded Novo Nordisk Golden Ticket to Advance Obesity and Inflammation Research
LEHI, Utah, March 11, 2025 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical c...
Halia Therapeutics opens Lehi lab, hopes to test new dementia drug within a year
Halia Therapeutics believes it is on the forefront of research to target chronic inflammation to tre...
Kaimana Close Up; Halia Parish
"I like to put my opinion and my thoughts in things," she said, "so I really like going into homecom...
Singapore Botanic Gardens restaurant The Halia to close after 25 years
SINGAPORE: Restaurant The Halia at the Singapore Botanic Gardens will shutter in mid-March after ope...
AFT Halia, A Custom Fighter Built by Models
They say motorcycle tuning and customization is a job only fit for men. Yet AMD Championships multip...
HALIA AFT Customs
Halia from AFT Customs is a Honda VT750BR full custom with a modified stock frame. All fenders & sid...